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Historically, though high infant mortality 
rates were recognized by the British medi-
cal community at least as early as the 1860s, 
the advent of neonatal intensive care is rela-
tively recent. In 1898, Dr. Joseph B. De Lee 
(1) established the first premature infant 
incubator station at the Chicago, Illinois 
Lying-in Hospital. The first American 
textbook on prematurity was published 
in 1922 (2). It was not until 1965 that the 
first American newborn intensive care unit 
(NICU) was opened at Yale University, but 
more importantly, only a few years later 
Egon Diczfalusy conceptualized the feto-
placental unit (3), which established that 
the fetus actively participates in its own 
physiologic development in utero. This 
represented a fundamental break with 
Victorian attitudes toward maternal con-
finement during pregnancy, and set the bar 
for reproductive physiology to this day.
Such breakthroughs as Helen Taussig’s 
surgical approach to the treatment of the 
Tetralogy of Fallot (4); the Liley Score for 
hyperbilirubinemia (5); the L/S ratio (6), 
Continuous Positive Airway Pressure ven-
tilation (7), antenatal steroids (8), and post-
natal exogenous surfactant to prevent and 
treat Respiratory Distress Syndrome (RDS) 
(9) all led inexorably to the fetus as a patient. 
It was the advent of antenatal steroids for 
lung immaturity that was the call to action 
for the Neonatology Community – the 
realization that there was a way to proac-
tively affect the outcome of preterm birth, 
not merely passive watchful waiting (For 
example, Dr. Gluck’s dictum that if the L/S 
ratio were less than 2:1, to wait for 2 weeks 
and retest). That challenge set the bar, and 
it remains to this day, given all of the ancil-
lary effects of antenatal steroids on multiple 
organs and systems.
The origins of Neonatology as a formal 
discipline were sown by investigators pas-
sionately curious about the limits of human 
physiology. Clement Smith would relate his 
story of how he and his pediatric colleagues 
were allowed to round on preterm infants at 
the Boston Lying-In Hospital in the 1950s, 
initially observing, and then providing 
minimal nourishment (a little glucose on 
the tongue) and comfort (warming lamps). 
One of Professor Smith’s more ambitious, 
forward-thinking, and observant Fellows, 
ME Avery, would express to her students 
how dissatisfied she was with the diagnosis 
of Hyaline Membrane Disease (HMD) as 
an inevitable post-mortem consequence 
of pulmonary obstructive disease. Instead, 
she took the initiative of studying lung sur-
factant in these infants, hypothesizing that 
they were surfactant deficient. She and Jere 
Mead demonstrated that the lung wash-
ings of preterm infants who died of HMD 
were deficient in surface tension-reducing 
activity in their airways (10), subsequently 
championing one of the first U.S. clinical 
trials for the use of antenatal glucocorti-
coids to stimulate lung surfactant produc-
tion, following on the first clinical use of 
antenatal glucocorticoids by Liggins and 
Howie in New Zealand (11). As a result of 
this intervention, the mortality rate due to 
RDS among infants less than 32 weeks ges-
tation fell dramatically, but the morbidities 
of preterm birth – bronchopulmonary dys-
plasia, necrotizing enterocolitis, retinopathy 
of prematurity, intraventricular hemor-
rhage, cerebral palsy – necessarily increased 
as a direct result of the increased survival, 
leaving the newly established discipline of 
Neonatology with the tandem challenges of 
further reducing morbidity, while decipher-
ing the underlying principles of physiology 
to predict and prevent the sequelae of pre-
term birth.
There is a long history of systematic 
approaches to determining where along the 
normal course of development any given 
preterm infant is at the time of birth. In 
1952 Dr. Virginia Apgar described the Apgar 
scoring system (12) as a formalized means 
of evaluating a newborn’s physiologic 
 condition at the time of birth. And then 
there were Lula Lubchenko’s standardized 
birthweights (13), which provided objec-
tive data for calibrating gestational age at 
birth. More recently, Doug Richardson (14) 
had devised the SNAP score. All of these 
efforts are designed to try and circumscribe 
the emergent and contingent character of 
preterm birth, much like the description 
of the process of Evolution itself, which 
has been equally elusive for the very same 
reasons. Identifying the predictors of neo-
natal physiology and well-being remains a 
challenge.
The only advance in Neonatology based 
on a priori scientific principles of fetal physi-
ology and adaptation was the discovery by 
Avery and Mead (10) that RDS was due to 
lung surfactant deficiency at birth. All of 
the other treatments and procedures were 
derived a posteriori from standard pediatric 
physiology reduced to its application to the 
preterm newborn. Over time, the discipline 
became aware that preterm infants are not 
merely small term infants, they are fetuses 
who have not achieved their full physiologic 
capacity. We have yet to discover the underly-
ing cause of preterm birth, or the fundamen-
tal phylogenetic mechanisms of adaptive 
physiology. We have not made any progress 
in ascertaining the first principles of human 
physiology as the basic scientific underpin-
ning Neonatology, other than to amass vol-
umes of clinical information as an empiric 
guide for managing preterm infants – 
it must be underscored that there is a 
 fundamental difference between informa-
tion and knowledge.
Now, armed with molecular biologic 
methods – genomics, proteomics, metabo-
lomics, phenomics, etc. – we must determine 
what principles determine the processes of 
physiologic adaptation at the cell-molecular, 
tissue, organ, systemic, and organismal lev-
els if we are to fulfill the  ultimate, and lofty 
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goal of Neonatology – for every newborn to 
achieve its genetic destiny. That is the Grand 
Challenge. When Mary Ellen Avery invited 
me as a basic scientist to join her research 
group as it transitioned from McGill 
University to Harvard Medical School in 
1974, she said to me “we need to provide 
science as the foundation for Neonatology, 
or we could do a lot of harm in the name of 
good.” Frontiers in Pediatrics: Neonatology 
is dedicated to the on-going reporting and 
encouragement of that effort.
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